glucorx technologies limited
glucorx technologies limited Company Information
Company Number
SC575629
Next Accounts
86 days late
Shareholders
gluco rx limited
Group Structure
View All
Industry
Manufacture of medical and dental instruments and supplies
Registered Address
dingwall business centre, strathpeffer road, dingwall, IV15 9QF
Website
inside-biometrics.comglucorx technologies limited Estimated Valuation
Pomanda estimates the enterprise value of GLUCORX TECHNOLOGIES LIMITED at £1.9m based on a Turnover of £1.9m and 0.98x industry multiple (adjusted for size and gross margin).
glucorx technologies limited Estimated Valuation
Pomanda estimates the enterprise value of GLUCORX TECHNOLOGIES LIMITED at £0 based on an EBITDA of £-621.5k and a 5.63x industry multiple (adjusted for size and gross margin).
glucorx technologies limited Estimated Valuation
Pomanda estimates the enterprise value of GLUCORX TECHNOLOGIES LIMITED at £0 based on Net Assets of £-8.8m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Glucorx Technologies Limited Overview
Glucorx Technologies Limited is a live company located in dingwall, IV15 9QF with a Companies House number of SC575629. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in September 2017, it's largest shareholder is gluco rx limited with a 100% stake. Glucorx Technologies Limited is a young, small sized company, Pomanda has estimated its turnover at £1.9m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Glucorx Technologies Limited Health Check
Pomanda's financial health check has awarded Glucorx Technologies Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
8 Weak
Size
annual sales of £1.9m, make it smaller than the average company (£16.6m)
- Glucorx Technologies Limited
£16.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (6.2%)
- Glucorx Technologies Limited
6.2% - Industry AVG
Production
with a gross margin of 39%, this company has a comparable cost of product (39%)
- Glucorx Technologies Limited
39% - Industry AVG
Profitability
an operating margin of -33.2% make it less profitable than the average company (6.3%)
- Glucorx Technologies Limited
6.3% - Industry AVG
Employees
with 21 employees, this is below the industry average (88)
21 - Glucorx Technologies Limited
88 - Industry AVG
Pay Structure
on an average salary of £48k, the company has an equivalent pay structure (£48k)
- Glucorx Technologies Limited
£48k - Industry AVG
Efficiency
resulting in sales per employee of £90.1k, this is less efficient (£176.8k)
- Glucorx Technologies Limited
£176.8k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Glucorx Technologies Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 19 days, this is quicker than average (38 days)
- Glucorx Technologies Limited
38 days - Industry AVG
Stock Days
it holds stock equivalent to 8 days, this is less than average (95 days)
- Glucorx Technologies Limited
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (11 weeks)
0 weeks - Glucorx Technologies Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5337.7%, this is a higher level of debt than the average (42.5%)
5337.7% - Glucorx Technologies Limited
42.5% - Industry AVG
GLUCORX TECHNOLOGIES LIMITED financials
Glucorx Technologies Limited's latest turnover from March 2023 is estimated at £1.9 million and the company has net assets of -£8.8 million. According to their latest financial statements, Glucorx Technologies Limited has 21 employees and maintains cash reserves of £54.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 21 | 22 | 21 | 24 | 23 | 29 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 22,173 | 5,310 | 60,472 | 106,784 | 162,575 | 213,567 |
| Intangible Assets | 54,167 | |||||
| Investments & Other | ||||||
| Debtors (Due After 1 year) | ||||||
| Total Fixed Assets | 22,173 | 5,310 | 60,472 | 106,784 | 162,575 | 267,734 |
| Stock & work in progress | 25,644 | 27,930 | 31,064 | 31,286 | 26,907 | 75,632 |
| Trade Debtors | ||||||
| Group Debtors | ||||||
| Misc Debtors | 66,743 | 51,333 | 47,339 | 44,387 | 95,560 | 25,782 |
| Cash | 54,167 | 74,516 | 62,391 | 34,160 | 30,393 | 114,303 |
| misc current assets | ||||||
| total current assets | 146,554 | 153,779 | 140,794 | 109,833 | 152,860 | 215,717 |
| total assets | 168,727 | 159,089 | 201,266 | 216,617 | 315,435 | 483,451 |
| Bank overdraft | ||||||
| Bank loan | ||||||
| Trade Creditors | 62,931 | 84,407 | 25,377 | 75,335 | 40,335 | 18,603 |
| Group/Directors Accounts | 8,844,198 | 7,294,198 | 5,929,198 | 4,729,198 | ||
| other short term finances | ||||||
| hp & lease commitments | ||||||
| other current liabilities | 99,025 | 992,720 | 628,117 | 275,861 | 3,371,103 | 1,713,465 |
| total current liabilities | 9,006,154 | 8,371,325 | 6,582,692 | 5,080,394 | 3,411,438 | 1,732,068 |
| loans | ||||||
| hp & lease commitments | ||||||
| Accruals and Deferred Income | ||||||
| other liabilities | ||||||
| provisions | ||||||
| total long term liabilities | ||||||
| total liabilities | 9,006,154 | 8,371,325 | 6,582,692 | 5,080,394 | 3,411,438 | 1,732,068 |
| net assets | -8,837,427 | -8,212,236 | -6,381,426 | -4,863,777 | -3,096,003 | -1,248,617 |
| total shareholders funds | -8,837,427 | -8,212,236 | -6,381,426 | -4,863,777 | -3,096,003 | -1,248,617 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 6,428 | 55,162 | 55,162 | 53,391 | 53,992 | 53,392 |
| Amortisation | ||||||
| Tax | ||||||
| Stock | -2,286 | -3,134 | -222 | 4,379 | -48,725 | 75,632 |
| Debtors | 15,410 | 3,994 | 2,952 | -51,173 | 69,778 | 25,782 |
| Creditors | -21,476 | 59,030 | -49,958 | 35,000 | 21,732 | 18,603 |
| Accruals and Deferred Income | -893,695 | 364,603 | 352,256 | -3,095,242 | 1,657,638 | 1,713,465 |
| Deferred Taxes & Provisions | ||||||
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | ||||||
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | ||||||
| Group/Directors Accounts | 1,550,000 | 1,365,000 | 1,200,000 | 4,729,198 | ||
| Other Short Term Loans | ||||||
| Long term loans | ||||||
| Hire Purchase and Lease Commitments | ||||||
| other long term liabilities | ||||||
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | -20,349 | 12,125 | 28,231 | 3,767 | -83,910 | 114,303 |
| overdraft | ||||||
| change in cash | -20,349 | 12,125 | 28,231 | 3,767 | -83,910 | 114,303 |
glucorx technologies limited Credit Report and Business Information
Glucorx Technologies Limited Competitor Analysis
Perform a competitor analysis for glucorx technologies limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in IV15 area or any other competitors across 12 key performance metrics.
glucorx technologies limited Ownership
GLUCORX TECHNOLOGIES LIMITED group structure
Glucorx Technologies Limited has no subsidiary companies.
glucorx technologies limited directors
Glucorx Technologies Limited currently has 2 directors. The longest serving directors include Mr Nilesh Nathwani (Sep 2017) and Mr Parag Khiroya (Sep 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Nilesh Nathwani | England | 63 years | Sep 2017 | - | Director |
| Mr Parag Khiroya | England | 61 years | Sep 2017 | - | Director |
P&L
March 2023turnover
1.9m
-5%
operating profit
-627.9k
0%
gross margin
39%
-2.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
-8.8m
+0.08%
total assets
168.7k
+0.06%
cash
54.2k
-0.27%
net assets
Total assets minus all liabilities
glucorx technologies limited company details
company number
SC575629
Type
Private limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
September 2017
age
8
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2023
previous names
inside biometrics international limited (August 2022)
accountant
NSO ASSOCIATES LLP
auditor
-
address
dingwall business centre, strathpeffer road, dingwall, IV15 9QF
Bank
-
Legal Advisor
-
glucorx technologies limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to glucorx technologies limited.
glucorx technologies limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GLUCORX TECHNOLOGIES LIMITED. This can take several minutes, an email will notify you when this has completed.
glucorx technologies limited Companies House Filings - See Documents
| date | description | view/download |
|---|
